Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

被引:166
作者
Abiru, S
Migita, K
Maeda, Y
Daikoku, M
Ito, M
Ohata, K
Nagaoka, S
Matsumoto, T
Takil, Y
Kusumoto, K
Nakamura, M
Komori, A
Yano, K
Yatsuhashi, H
Eguchi, K
Ishibashi, H
机构
[1] NHO Nagasaki Med Ctr, Clin Res Ctr, Omura 8568652, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Nagasaki 852, Japan
[3] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 852, Japan
关键词
cytokines; interleukin-6; non-alcoholic steatohepatitis; tumor necrosis factor-alpha;
D O I
10.1111/j.1478-3231.2005.01191.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although the pathogenesis of non-alcoholic steatohepatitis (NASH) remains poorly understood, proinflammatory cytokines seem to play an important role in the process of NASH. We have undertaken this study in order to elucidate the role of proinflammatory cytokines and their soluble receptors in NASH patients. Methods: Serum cytokines and soluble cytokine receptors levels were determined using an enzyme-linked immunosorbent assay kit in 23 patients with NASH, 21 patients with simple steatosis, and 18 healthy volunteers. Results: Patients with NASH had significantly higher serum tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) levels than did the simple steatosis patients. Similarly, when compared with simple steatosis, NASH was associated with higher soluble TNF receptor1 (sTNFR1) and soluble IL-6 receptor (sIL-6R) levels, and a significant positive correlation was seen between the levels of sTNFR1 and aminotranferases in NASH patients. Conclusions: This study shows that circulating TNF-alpha/sTNFR1 and IL-6/sIL-6R levels are significantly increased in NASH patients as compared with simple steatosis patients and healthy volunteers, and that these increased levels may be implicated in the pathogenesis of NASH.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 34 条
  • [1] Bemelmans MHA, 1996, CRIT REV IMMUNOL, V16, P1
  • [2] Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
    Brunt, EM
    Janney, CG
    Di Bisceglie, AM
    Neuschwander-Tetri, BA
    Bacon, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) : 2467 - 2474
  • [3] Nonalcoholic steatohepatitis: Definition and pathology
    Brunt, EM
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 3 - 16
  • [4] Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?
    Bugianesi, E
    Zannoni, C
    Vanni, E
    Marzocchi, R
    Marchesini, G
    [J]. DIGESTIVE AND LIVER DISEASE, 2004, 36 (03) : 165 - 173
  • [5] NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
    Chitturi, S
    Abeygunasekera, S
    Farrell, GC
    Holmes-Walker, J
    Hui, JM
    Fung, C
    Karim, R
    Lin, R
    Samarasinghe, D
    Liddle, C
    Weltman, M
    George, J
    [J]. HEPATOLOGY, 2002, 35 (02) : 373 - 379
  • [6] Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
    Crespo, J
    Cayón, A
    Fernández-Gil, P
    Hernández-Guerra, M
    Mayorga, M
    Domínguez-Díez, A
    Fernández-Escalante, JC
    Pons-Romero, F
    [J]. HEPATOLOGY, 2001, 34 (06) : 1158 - 1163
  • [7] Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine
    Czaja, MJ
    [J]. HEPATOLOGY, 2004, 40 (01) : 19 - 22
  • [8] Inflammation: the link between insulin resistance, obesity and diabetes
    Dandona, P
    Aljada, A
    Bandyopadhyay, A
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 4 - 7
  • [9] Steatohepatitis: A tale of two "hits"?
    Day, CP
    James, OFW
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : 842 - 845
  • [10] Cytokine regulation of liver injury and repair
    Diehl, AM
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 174 : 160 - 171